Taylor Morrison Home
TMHC
Meta Platforms
META
Meritage Homes
MTH
D.R. Horton
DHI
Toll Brothers
TOL
US Stock MarketDetailed Quotes
TELO Telomir Pharmaceuticals
- 4.105
- -0.245-5.63%
Trading Mar 20 14:18 ET
122.18MMarket Cap-7.40P/E (TTM)
4.535High4.060Low56.35KVolume4.350Open4.350Pre Close240.37KTurnover0.32%Turnover RatioLossP/E (Static)29.76MShares9.39052wk High186.59P/B71.69MFloat Cap3.11052wk Low--Dividend TTM17.46MShs Float20.720Historical High--Div YieldTTM10.92%Amplitude3.110Historical Low4.265Avg Price1Lot Size
Telomir Pharmaceuticals Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If...
64
10
1
$Telomir Pharmaceuticals (TELO.US)$
Breakthrough: New Cancer Drug Cuts Prostate Tumors by Half While Reducing Chemo Toxicity
Breakthrough: New Cancer Drug Cuts Prostate Tumors by Half While Reducing Chemo Toxicity
$Telomir Pharmaceuticals (TELO.US)$ Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
Benzinga· 4 mins ago
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model with aggressive cancer cells.
The company says that Telomir-1 actively suppresses cancer growth and protects against chemothe...
Benzinga· 4 mins ago
On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model with aggressive cancer cells.
The company says that Telomir-1 actively suppresses cancer growth and protects against chemothe...
1
$Telomir Pharmaceuticals (TELO.US)$ y no options ?
$Telomir Pharmaceuticals (TELO.US)$
Could This Anti-Aging Compound Revolutionize Treatment for Alzheimer's and Macular Degeneration?
Could This Anti-Aging Compound Revolutionize Treatment for Alzheimer's and Macular Degeneration?
$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Wednesday, 26th February at 8:00 am
New Study Confirms Telomir-1 Also Reverses Oxidative Stress, Preserves Cellular Integrity, and Prevents Cell Death by Protecting Mitochondria-The Cell's Power Source and Gatekeeper of Life and Death
MIAMI, FLORIDA / ACCESS Newswire / February 26, 2025 / Telomir Phar...
Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines
Wednesday, 26th February at 8:00 am
New Study Confirms Telomir-1 Also Reverses Oxidative Stress, Preserves Cellular Integrity, and Prevents Cell Death by Protecting Mitochondria-The Cell's Power Source and Gatekeeper of Life and Death
MIAMI, FLORIDA / ACCESS Newswire / February 26, 2025 / Telomir Phar...
1
NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press rele...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press rele...
79
20
10
$Telomir Pharmaceuticals (TELO.US)$
Can Telomir's Silver Ion Innovation Transform Medical Treatment? Key Markets React
Can Telomir's Silver Ion Innovation Transform Medical Treatment? Key Markets React
$Telomir Pharmaceuticals (TELO.US)$
Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
Friday, 21st February at 8:00 am
MIAMI, FLORIDA / ACCESS Newswire / February 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) (Ag⁺) and the highly reactive Silver(II) (Ag²⁺) i...
Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market
Friday, 21st February at 8:00 am
MIAMI, FLORIDA / ACCESS Newswire / February 21, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), or Telomir, a leader in age-reversal science, today announced a breakthrough achievement-Telomir-1 has successfully captured and stabilized both Silver(I) (Ag⁺) and the highly reactive Silver(II) (Ag²⁺) i...
1
$Telomir Pharmaceuticals (TELO.US)$
Revolutionary Eye Disease Treatment Emerges: Telomir's New Drug Shows Remarkable Promise for AMD Patients
Revolutionary Eye Disease Treatment Emerges: Telomir's New Drug Shows Remarkable Promise for AMD Patients
No comment yet
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
ASteffie :
発生する888 :
発生する888 発生する888 : there is still hope pray
keene86 : Jag bro.. how come in quantum section , qmco wasn't included.. just curious..![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
wammerjammer : Appreciate the info. Im new to trading and trying to figure all this out. Ill look into these companies
View more comments...